People: Apellis Pharmaceuticals Inc (APLS.OQ)
16 Aug 2019
Dr. Pascal Deschatelets Ph.D. serves as Co-Founder, Chief Operating Officer of the Company. Dr. Deschatelets co-founder of our company and has served as our Chief Operating Officer since our inception in 2009. Dr. Deschatelets also co-founded Potentia and served as its Chief Operating Officer from 2001 to September 2016 and is a cofounder of Revon. Dr. Deschatelets received his Ph.D. in organic chemistry from the University of Montreal and his post-doctoral training in the laboratory of Dr. George Whitesides at Harvard University.
|Total Annual Compensation, USD||625,000|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,237,360|
|Fiscal Year Total, USD||1,862,360|